Cynvenio Biosystems Cynvenio, St. Luke's Partner on Breast Cancer Study The study, launched today, aims to evaluate the use of liquid biopsy and natural killer cell testing for the early detection of recurrent breast cancer. Color Genomics Maps New Customer Inroads With Cancer Dx Testing Partnerships Premium The company has made agreements with two cancer diagnostics firms — GenomeDx, and Cynvenio — bundling its hereditary germline analysis with their somatic tests. Cynvenio Signs International Distribution Agreements for Liquid Biopsy Tests While Cynvenio will still perform testing in its own lab right now, the firm's CEO said that interested labs could move the technology in house in the future if they desire. Cynvenio Offers Breast Cancer Recurrence Monitoring, Data Still to Come Premium The firm has launched a yearly subscription program that includes quarterly blood tests to look for genetic and proteomic signs of metastasis or cancer recurrence. Cynvenio, Color to Offer Combined Hereditary and Somatic Cancer Blood Test The combination test will allow clinicians to analyze breast cancer patients for germline hereditary cancer markers at the same time as they search their blood for driver mutations. Jan 26, 2017 Milenia Labs to Distribute Cynvenio ClearID Breast Cancer Test in Mexico Dec 28, 2016 Pancreatic Cancer Study Finds NGS-Based Liquid, Tissue Biopsies Provide Discordant Results Premium Dec 28, 2015 Cynvenio, ATGen Initiate Pilot Study of Combo Cancer Test Dec 4, 2015 In Brief This Week: Pacific Biosciences; Epigenomics; Cynvenio Biosystems; and More Sep 8, 2015 Cynvenio Receives CAP Accreditation Jun 19, 2015 Cynvenio Anticipates Clinical Growth Supported by $25M Series B, Plans China Expansion Premium Jun 18, 2015 Cynvenio, Cure Forward Partner to Improve Patient Access to Genomic Testing Data Jun 17, 2015 Cynvenio Biosystems Raises $25.5M in Series B Round Jan 13, 2015 Thermo Fisher, Cynvenio Ink Distribution Agreement for LiquidBiopsy Platform Sep 18, 2014 UCSD Spinout Diagnologix Using Recent NIH Grants to Develop Microbubble Tech for CTC Isolation Premium Sep 4, 2014 Cynvenio Launches Early Access Program for Liquid Biopsy Platform Dec 11, 2013 CollabRx to Provide Cynvenio with Clinical Data Interpretation Services Jul 9, 2013 Cynvenio Bio Gains CLIA Certification for NGS Lab Apr 11, 2013 Cynvenio to Offer Clinical PCR Testing of Isolated Circulating Tumor Cells for Select Targets Premium Apr 10, 2013 Cynvenio Offering NGS Analysis of Isolated Circulating Tumor Cells Using AmpliSeq Panel Premium Mar 21, 2013 Dx Focus: Meridian's Illumigene Group A, B Strep Tests; Cynvenio Biosystems' LiquidBiopsy Service Premium Feb 7, 2012 Cynvenio Gets SBIR Awards from NCI for CTC-based Tests Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.